MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0006233
MBS Lifescience Private Limited
MBS Lifescience Private Limited - pharma in Baddi, Himachal Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹183.49 Cr
▲ 34% YoY
Net profit · FY 2025
₹59.7 Lakh
Net margin 0.3%
EBITDA · FY 2025
₹1.88 Cr
EBITDA margin 1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹15.8 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About MBS Lifescience Private Limited
Data last updated:
MBS Lifescience Private Limited is a private limited company based in Baddi, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U33119HP2020PTC008181. Its GSTIN is 02AANCM9750F1ZC (Himachal Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sumit Aggarwal and Akash Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Opp Dsk Dharam Kanta Vill. Karuan Sai Road Baddi, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2025, the company reported a revenue of ₹183.49 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹59.7 Lakh (net margin 0.3%) and EBITDA of ₹1.88 Cr (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years.
As per MCA filings, the company has open charges of ₹15.8 Cr on record.
MBS Lifescience Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0006233).
Company details
CIN U33119HP2020PTC008181
Registration Number 008181
Incorporation Date 30 October 2020
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0006233
Key People
Sumit Aggarwal Director Akash Gupta Director Recognitions & Rankings of MBS Lifescience
Contact details
MBS Lifescience Private Limited's registered office is in Baddi, Himachal Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressOpp Dsk Dharam Kanta Vill. Karuan Sai Road Baddi, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
To see the full contact details of MBS Lifescience Private Limited, buy the company report.
Comprehensive company report
MBS Lifescience Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of MBS Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of MBS Lifescience Private Limited, buy the company report.
Financials of MBS Lifescience Private Limited
FY 2025 filings availableMBS Lifescience Private Limited reported revenue of ₹183.49 Cr (up 34% YoY) for FY 2025.
Revenue · FY 2025
₹183.49 Cr ▲ 34%
Net profit · FY 2025
₹59.7 Lakh margin 0.3%
EBITDA · FY 2025
₹1.88 Cr margin 1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 34%
3 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 8% over three years, including 34% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.88 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹59.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of MBS Lifescience Private Limited, buy the company report.
Board of directors of MBS Lifescience Private Limited
MBS Lifescience has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Aggarwal | Director | 30 Oct 2020 | 6 Years 0 Months | Current |
| Akash Gupta | Director | 30 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
MBS Lifescience Private Limited is compared with the 9 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Madhya Bharat Phosphate Private Limited | ₹184.01 Cr (FY 2025) | 28.0% | Mumbai, Maharashtra, India | |||
| Naxpar Pharma Private Limited | ₹183.89 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Merck Performance Materials Private Limited | ₹183.8 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Shivam Castor Products Private Limited | ₹183.64 Cr (FY 2024) | -11.0% | Meshana, Gujarat, India | |||
| MBS Lifescience Private Limitedthis company | ₹183.49 Cr (FY 2025) | ₹59.7 Lakh | 0.3% | 34.0% | Baddi, Himachal Pradesh, India | |
| Infutec Healthcare Limited | ₹183.11 Cr (FY 2021) | -22.0% | Mumbai, Maharashtra, India | |||
| Rajdhani Petrochemicals Private Limited | ₹183.01 Cr (FY 2025) | 46.0% | Ahmedabad, Gujarat, India | |||
| International Herbal Corporation Private Limited | ₹182.94 Cr (FY 2025) | 0.0% | Haridwar, Uttarakhand, India | |||
| Arkray Healthcare Private Limited | ₹182.68 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Albaugh India Private Limited | ₹182.64 Cr (FY 2025) | 93.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of MBS Lifescience Private Limited, buy the company report.
Auditor
MBS Lifescience Private Limited is audited by J P GUPTA ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J P GUPTA ASSOCIATES | FY 2023 | 000056N |
Shareholding
The shareholding of MBS Lifescience Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of MBS Lifescience Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15.8 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 May 2023 | 100746914 | Axis Bank Limited | ₹4 Cr | Open | |
| 06 Feb 2023 | 100679256 | Axis Bank Limited | ₹8.5 Cr | Open | |
| 17 Dec 2021 | 100526675 | Hdfc Bank Limited | ₹3 Cr | Open | |
| 18 Sep 2021 | 100496118 | Hdfc Bank Limited | ₹30 Lakh | Open |
To see the full charge records of MBS Lifescience Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving MBS Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for MBS Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
MBS Lifescience has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AANCM9750F1ZC | Himachal Pradesh | Active | 14 Nov 2020 |
To see the full GST registrations and return filing status of MBS Lifescience Private Limited, buy the company report.
Recent activity
MBS Lifescience Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Monika Garg ceased to be Director on 04 Aug 2023.
AGM
Mbs Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mbs Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge with Axis Bank Limited of Rs. 850.00 Lakh registered on 06 Feb 2023 with Charge ID 100679256 was modified on 23 Aug 2023.
Ceased
Monika Garg ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 400.00 Lakh with Charge ID 100746914 was registered on 11 May 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 850.00 Lakh with Charge ID 100679256 was registered on 06 Feb 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 300.00 Lakh with Charge ID 100526675 was registered on 17 Dec 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 30.00 Lakh with Charge ID 100496118 was registered on 18 Sep 2021.
Appointed
Akash Gupta was appointed as Director.
Appointed
Monika Garg was appointed as Director.
Appointed
Sumit Aggarwal was appointed as Director.
Incorporation
30 Oct 2020
Mbs Lifescience Private Limited was registered on 30 Oct 2020 with Roc Himachal Pradesh & aged 6 years 11 days as per MCA records.
Frequently asked questions
MBS Lifescience is an active private limited company based in Baddi, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 October 2020 (6+ years old) and is registered under CIN U33119HP2020PTC008181.
MBS Lifescience has 2 current directors:
- Sumit Aggarwal - Director
- Akash Gupta - Director
The latest financial statements of MBS Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of MBS Lifescience is 02AANCM9750F1ZC, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of MBS Lifescience is U33119HP2020PTC008181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MBS Lifescience was incorporated on 30 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of MBS Lifescience by revenue are Madhya Bharat Phosphate Private Limited, Naxpar Pharma Private Limited, Merck Performance Materials Private Limited, Shivam Castor Products Private Limited, Infutec Healthcare Limited and 4 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Monika Garg ceased to be Director on 04 Aug 2023. Akash Gupta was appointed as Director on 30 Oct 2020. Monika Garg was appointed as Director on 30 Oct 2020. MBS Lifescience has 4 board changes on record in total.
Yes, MBS Lifescience is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0006233).
The registered office of MBS Lifescience is at Opp Dsk Dharam Kanta Vill. Karuan Sai Road Baddi, Himachal Pradesh, India – 173205.
MBS Lifescience operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages